Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab synovial predictors of response in rheumatoid arthritis
ISRCTN36847425Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2001
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of infliximab in rheumatoid arthritis (RA), sponsored by Amsterdam University Medical Center. Primary endpoints: Primary immunohistological outcome and Primary clinical outcome. Started Apr 2001; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN36847425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN36847425.